Shaieb 2002
Methods | Treatment allocation by birth date Independent, non blinded assessment Mean follow‐up: 33 months Loss to follow‐up: 12 patients in total (excluded from analysis) Graft re‐ruptures (4 patients in total, excluded from analysis): 1 PT (traumatic), 1 PT (atraumatic) and 2 HT (traumatic) | |
Participants | USA 82 participants with acute or chronic isolated unilateral ACL tears Group allocation data for 66 participants (after excluding lost to follow‐ups and graft re‐ruptures) PT: n = 31 (17 acute, 14 chronic), mean 32 years (14 to 48 years), 26 males / 7 females HT: n = 35 (14 acute, 21 chronic), mean 30 years (14 to 53 years), 21 males / 16 females | |
Interventions | Arthroscopically‐assisted ACL reconstruction with: 1. Patellar tendon (single incision, proximal fixation ‐ round‐head cannulated, noncutting, metal interference screw; tibial fixation ‐ interference screw) versus 2. Hamstring tendon: semitendinosus/gracilis tendons (4 strands; single incision, proximal fixation ‐ round‐head cannulated, noncutting, metal interference screw; tibial fixation ‐ interference screw) | |
Outcomes | Mean 33 months follow‐up for: Lysholm, KT‐1000 (89N,134N, manual maximum), range of motion, pivot shift; return to activity, patient satisfaction, Cincinnati, Lachman (mean side to side difference), return to sport, thigh circumference, patellofemoral pain | |
Notes | No additional methodological information or individual patient data were received from the authors. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | High risk | Treatment allocation by birth date. |
Allocation concealment (selection bias) | High risk | |
Blinding (performance bias and detection bias) All outcomes | High risk | |
Incomplete outcome data (attrition bias) All outcomes | High risk | Complete clinical data was not available for 13 of the patients available for follow‐up. These patients completed questionnaires by mail only. |
Selective reporting (reporting bias) | High risk | |
Other bias | High risk | Baseline characteristics for all patients entered into the trial were not reported. |